A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis

Area of Science:

• Neuroimmunology
• Virology
• Genetics

Background:

• Recent studies suggest Epstein-Barr virus (EBV) may cause multiple sclerosis (MS).
• The precise mechanisms of EBV's role in MS pathogenesis and its specificity are unclear.
• Understanding EBV-host interactions is crucial for elucidating MS etiology.

Purpose of the Study:

• To investigate the association between EBV interactors and genetic loci linked to MS.
• To explore the role of EBV in MS-specific pathogenetic mechanisms.
• To identify potential therapeutic targets by analyzing EBV-host interactions in MS.

Main Methods:

• Analysis of genetic loci associated with MS and other diseases for enrichment of EBV interactor genes.
• Transcriptome analysis of MS blood and brain samples to identify dysregulated EBV interactors.
• Investigation of EBV nuclear antigen 2 (EBNA2) binding sites and its colocalization with host factors (CTCF, POLR2A).
• Assessment of EBNA2 allele effects on CD40 gene expression and association with MS risk.

Main Results:

• Genes encoding EBV interactors were enriched in MS-associated genetic loci, but not in loci for other diseases.
• Dysregulation of MS-associated EBV interactors impacting the CD40 pathway was observed in MS transcriptomes.
• EBV nuclear antigen 2 (EBNA2) binding sites were identified, often colocalizing with CTCF and POLR2A in the MS brain.
• The 1.2 EBNA2 allele was found to downregulate CD40 expression and associate with increased MS risk.

Conclusions:

• Host and viral genetic factors converge in MS-specific pathogenetic mechanisms.
• EBV, particularly through EBNA2, plays a significant role in MS pathogenesis.
• The findings highlight potential therapeutic strategies targeting EBV-host interactions in MS.